INTRODUCTION
The incidence of prostate cancer in Korea has dramatically increased in recent years. 1 This increase is associated with an aging population, westernization of dietary habits, and widespread use of prostate-specific antigen (PSA) testing. 2 In 1999, prostate cancer was the 10th most common cancer in Korean men, but became the 5th most common cancer by 2014.
1 D'Amico's classification has been the most widely accepted risk stratification model for predicting the prognosis of prostate cancer. [3] [4] [5] This system divides prostate cancer into low-, intermediate-, and high-risk disease using the Gleason score, serum PSA level, and Clinical T stage. 6 According to D'Amico's classification, a Gleason score of 6 is regarded as low risk, 7 as intermediate risk, and ≥8 as high risk. 6 However, as treatment methods for prostate cancer are varied and individualized, more accurate classification of prostate cancer grade is clinically needed. In this regard, in 2014, a new grading system for prostate cancer was introduced by the International Society of Urological Pathology (ISUP), which divided the Gleason score into 5 groups. [7] [8] [9] [10] After the introduction of the new 5-tiered grading system, several Western studies validated the predictive role of the new system and reported its superiority over the previous grading systems. 7, 9, 10 However, the new 5-tiered grading system has not been vali- 
MATERIALS AND METHODS
The present study protocol was reviewed and approved by the Seoul National University Hospital Institutional Review Board (approval number: 16-2014-145 Gleason group, and the presence of surgical margin were significantly associated with BCR-free survival, in addition to preoperative variables (Table 3) . In multivariate analysis, patho- 
DISCUSSION
The new 5-tiered grading system has proven its value in predicting oncological outcomes in Western patients with prostate cancer. 7, 19 However, its value in Asian prostate cancer patients remained to be determined before it could be clinically applied.
Considering the worse pathological characteristics and oncological outcomes of the disease in Asians than in Western pa- HR: hazard ratio, CI: confidence interval, BMI: body mass index, PSA: prostate-specific antigen, MRI: magnetic resonance imaging.
tients, 11,13-15 it was not possible to apply the new grading system as is, on Asians. In the current study, in more than one-third of the patients, the disease was locally advanced (as observed through on pathologic examination), which was significantly higher than the results of Western studies, even though the PSA level was not higher than that in previous studies. 12, 20 In addition, the Gleason grade was also higher than in some Western studies. In this study, 30.8% of patients had grade 3-5 disease, which was higher than the 24.1% reported by a previous Western study, 20 but was in accordance with the results of another study. 13 These findings might affect the predictive value of the 5-tiered system. Therefore, its prognostic value needs to be validated in Korean patients.
In this study, the biopsy grade group sequentially predicted the 5-year BCR-free survival, although statistical significance was not achieved between the groups. In other words, the new grading system might be helpful for predicting 5-year BCR-free survival using preoperative and biopsy-related variables. 19 In addition, preoperative PSA level and % positive core, well-known predictors of pathologic and oncological outcomes, 21 were also reported to be significant predictors of BCR-free survival after surgery. Although not a predictor of oncological outcomes, the role of multiparametric MRI needs to be assessed in a future study, because some of the MRI performed in this study was not multiparametric, and a standardized reporting system was not applied. 22, 23 In previous studies, MRI was reportedly valuable for predicting tumor characteristics before surgery. 24 However, in pathologic grade, the new 5-tiered system may have only limited value in predicting prognosis of prostate cancer after radical prostatectomy, especially in patients with grade groups 3-5. This study found no difference between pathologic grade groups 3-5, which was different from the finding in Western studies. 20 These results might be due to the small num- 27, 28 In this regard, patients with Gleason score 7 need to be further divided into 2 groups, and treatment/prognosis needs to be explained based on these results. Because grades 2 and 3 account for more than half of all patients, the value of the new system should not be overlooked, although its value in patients with grade ≥3 needs to be carefully interpreted.
Moreover, another limitation of the current study is that biopsy and pathologic Gleason score have not been reviewed by pathologists using 2005 ISUP Gleason system. In this regards, the changes in Gleason score over time cannot be adjusted in the current study. 29 Although some argued that the impacts of
Gleason system change on patient management and prognosis is uncertain, 30 more studies with a pathologic review of the Gleason score thought to be needed to validate the results of the current study.
Final limitation of the current study thought to be selection bias. Because we excluded a considerable proportion of patients with aggressive pathologic features before analysis, the results of the current need to be interpreted with cautions.
The current study has several limitations, including the retrospective design. Although this was one of the largest Korean studies in this field, an even larger number of patients needs to be included for the analysis to accurately evaluate the role of the grading system for prostate cancer, especially in Gleason grade groups ≥4. In addition, the relatively long enrollment period is another limitation which might affect the results of the current study. Although this study may only be applicable to nonmetastatic prostate cancer patients who underwent radical prostatectomy, the results may be of value to clinicians, because this large-scale Asian study assessed the predictive value of the new 5-tiered grading system.
CONCLUSIONS
The new 5-tiered grading system could be useful for predicting oncological outcomes in Korean patients with prostate cancer with Gleason grade groups 1-3. However, its role for distinguishing outcomes between patients with Gleason grade groups 3-5 of the disease needs to be validated before application of this system in Korea.
